Relay Therapeutics to Participate in Two Upcoming Investor Conferences

Company Overview - Relay Therapeutics is a clinical-stage precision medicine company focused on transforming the drug discovery process through advanced computational and experimental technologies [2] - The company aims to develop life-changing therapies, particularly in targeted oncology and genetic disease indications [2] - Relay Therapeutics utilizes its proprietary Dynamo® platform, which integrates various computational and experimental approaches to target previously challenging protein targets [2] Upcoming Events - Management will participate in two fireside chats, which will be webcast live and accessible through the company's website [1] - The events include participation in TD Cowen's 45th Annual Health Care Conference on March 5, 2025, and Barclays 27th Annual Global Healthcare Conference on March 11, 2025 [3]